Our aim is to develop new and improved therapies that offer benefits over existing treatment options
Roche has a portfolio of therapies for the treatment of cancer as well as diseases including haemophilia, central nervous system disorders, lung disorders and inflammatory diseases.
Our products currently supported on rocheresources.co.uk
Further Information
Congress and Meetings
Highlights from the latest international and national congresses and Roche-organised meetings.
M-GB-00003975
Date of preparation: June 2021